HRA-ASIA | World Famous Doctor and Scientist Team

page-template,page-template-full_width,page-template-full_width-php,page,page-id-17288,ajax_fade,page_not_loaded,,vertical_menu_enabled,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive

World Famous Doctor and Scientist Team

Benno jiao
RE-Stem Founder and President
Founder & C.E.O of Re-Stem Biotech

Has been engaged in biotechnology research and development and promotion work.

Over the years, Benno Jiao has achieved remarkable results in the field of biotechnology research and development and application, and obtained 6 national patent technologies.
In 2013, Jiao Yang was selected by the People’s Daily as “The New Leader of the Economy in 2013”.

Shoushu Jiao

RE-Stem Chief Scientist
Visiting Professor, Capital Medical University
Member of American Society of Neuroscience; Member of the International Brain Research Society

The first batch of senior intellectuals in the medical profession after the founding of New China
In the early 1980s, he developed the use of stem cells to treat senile dementia and stroke and became the world’s stem cell research leader.
He has published 56 academic research papers, and participated in the compilation of 7 academic monographs, including “Nervous System Disease Symptoms”, “Human Anatomy Graphic Dictionary”, “Brain Tissue Transplantation” and other monographs.

Wang Tie
RE-Stem Chief Medical Officer
Doctor of Medicine, Master of Economics
RE-Stem, Deputy Chief Engineer, Los Angeles R&D Center
Director of China Non-Public Medical Institutions Association
General Secretary of the Biotechnology and Cell Applications Committee

He has more than 20 years of experience in medical clinical research, and has several patents in the field of stem cells. In particular, his research on diabetes and liver diseases is in leading position in China.

Wu MuTain
RE-Stem Chief Technical Officer

Professor of the University Hospital of Hong Kong, deputy director of the State Key Laboratory of Brain and Cognition, University of Hong Kong, deputy dean of the Guangdong, Hong Kong and Macau Central Regeneration Institute of Jinan University, an internationally renowned scholar in the field of neurological injury research.

Jyothi Devakum
Chief Scientific Officer of RE-Stem
Nygard Biotech Corporation Vice President of Technology and Chief Scientific Officer; Principal Consultant, Evolvis

With more than 10 years of experience in stem cell research and research and development, he has worked in a number of international organizations. Her main research topic is research on stem cell related technologies and application licenses. She has international stem cell management expertise, and has centuries of work experience and clinical trials in cGMP and GCP. She is one of the top scientists in the international stem cell field.

She received her Ph.D. in biotechnology. Subsequently, she conducted a postdoctoral research project in France. She later worked for several years in the pharmaceutical field of some biopharmaceutical companies in Europe and the United States. Then go to Malaysia, Singapore and the United States to study stem cell applications, manage stem cell banks and act as consultants. She is also working on the CellR4 editorial board and the Huada Gene Health Science Advisory Committee.

Elliot B.Lander M.D
American College of Surgeons
Member of the International Society of Cell Surgery
Co-founder of the Cell Surgery Network
California Medical Association Urology Reviewer

So Kwok Fai

RE-Stem Chief Scientific Advisor

Academician of the Chinese Academy of Sciences, academician of the National Association of Inventors, and dean of the Guangdong, Hong Kong and Macao Central Nervous Regeneration Research Institute of Jinan University, Guangzhou, has 26 patents.

Mark Berman

RE-Stem Chief Medical Officer

The founder of the Cell Surgery Network ® , the president of the American Stem Cell Association, the American Academy of Plastic Surgery, and the American College of Surgeons Lifetime Achievement Award in 2015.

Steven Alan Schweller
RE-STEM Biotech Vice President

Graduated from the University of Canterbury, UK
Honorary Degree in B.H.S, Bowmanville, Ontario, Canada
One of the founders of a well-known American research center
One of the core research members of the International Regenerative Medicine Research and Development Center
The leader of the international regenerative medicine industry
Senior application specialist for stem cell anti-aging

Xu Qunyuan
RE-Stem Medical Consultant

Former President of Beijing Capital Medical University, President of Beijing Society for Neurotransplantation and Rehabilitation, Director of China Institute of Neuroscience, Executive Director and Deputy Secretary General of International Anatomy Society

Dr. Hee Young Lee
Founder and president
Founder & C.E.O of Medikhan

World-renowned stem cell expert and chairman of Medikan

Chen Mingzhe
RE-Stem Chief Scientific Advisor; Doctor of Medicine, Professor
1993-1996 Beijing Medical University Third Hospital; 2006 Vice President of Tsinghua University School of Medicine; US Western Cardiology Institute member, visiting professor; US Senator Ted Kennedy’s private doctor

David A.Howe

RE-Stem Chief Medical Consultant

A member of the former President’s Medical Expert Group, a member of the American Academy of Anti-Aging Medicine, founder and dean of the San Diego Preventive Medicine Clinic, and vice president and medical director of Stemedica, USA

RE- Stem Team and Other Professional Associations

China Non-Public Medical Institutions Association
Secretary General of the Biotechnology and Cell Application Committee

China Non-Public Medical Institutions Association (CNMIA) is a first-level association registered by the Ministry of Civil Affairs. Its purpose is to implement the national health and family planning work policies and policies to deepen the reform of the medical and health system. The Committee of Biotechnology and Cell Application of China’s Non-Public Medical Institutions Association aims to deepen the reform of the medical and health system, improve the management level and professional level of cell therapy technology in non-public medical institutions, and promote the construction and development of cell therapy disciplines in non-public medical institutions.

The International Cell Surgical Society (ICSS)

RE-Stem is also a member of ICSS . ICSS is a non-profit organization registered in the United States by 11 world-renowned scientific and medical experts. Its mission is to evaluate early new technologies in the cell field, support early trials, and promote later technologies. At present, the evaluation expert committee is preparing to expand to 17 people, of which 2 people occupy China.

RE-Stem holding a lecture at the 13th International Conference on Neural Transplantation and Rehabilitation

Organized by the International Association of Neural Transplantation and Restoration, the 13th International Conference on Neurorestoration, jointly hosted by Beijing Capital Medical University, Resittan Bio, and Beijing Brain Disease Research Institute, was held in China for the first time.

Professor Sir John Gurdon (2012 Nobel Prize winner in Physiology or Medicine), Fred Gage (President of the American Society of Neuroscience and Chairman of the Society for Autologous Stem Cell Research) and more than 30 world-class neurologists attended the conference. At the conference, RE-Stem also shared “The Clinical Application of Autologous Stem Cells in Osteoarthritis & Childhood Autism” and “Clinical Application of Autologous Stem Cells in Neurodegenerative Diseases”